TAS 2021 10th Annual Toledo Allergy Society Conference

September 8, 2021

It is an exciting time in the field of allergy and immunology. This CME program is designed to allow attendees to continue exploring the Immunology Frontier.  Covered topics include current and emerging treatments in angioedema, immunodeficiency and food allergy. 

This conference is designed to meet the educational needs of physicians, residents, fellows & medical students.   It may also meet the educational needs of PA’s, NP’s pharmacists, nurses, EMT’s respiratory therapists, medical assistants and other interested health care professionals.  The conference will include interactive and didactic lectures by distinguished national speakers with local faculty participation.  

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology (ACAAI) and Toledo Allergy Society (TAS). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Target Audience

Practicing allergists
Allergy practitioners
Allied health professionals

Learning Objectives

Upon completion of this activity the participant should be able to:

  1. Review diagnosis and treatment of different types of angioedema and prioritize steroid sparing treatment options for patients with chronic urticaria
  2. Recommend early food introduction based on current guidelines for prevention of food allergies
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. 

Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Attendance
Course opens: 
09/08/2021
Course expires: 
12/31/2023
Event starts: 
09/08/2021 - 7:30am CDT
Event ends: 
09/08/2021 - 4:15pm CDT
Add to calendar: 
Rating: 
0

TAS 2021: 10th Annual Toledo Allergy Society Conference

Wednesday, September 8, 2021
Hilton Garden Inn, Perrysburg, Ohio 43551

7:30 am                       Registration / Breakfast

7:45 am                       WELCOME AND INTRODUCTIONS
                                      Svetlana Kriegel, MD, President, Toledo Allergy Society
                                     M. Razi Rafeeq, MD

8:00 – 8:45 am            CHRONIC RHINITIS AND RHINOSINUSITIS: DIAGNOSIS & MANAGEMENT, Michael Blaiss, MD

8:45 – 9:30 am            WHEN TO SUSPECT IMMUNODEFICIENCY, Alan Baptist, MD, MPH

9:30 – 10:00 am          PANEL DISCUSSION,  M. Razi Rafeeq, MD, Moderator
                                       Summarize management and treatment modalities for asthma and chronic rhinosinusitis

10:00 am                     Break and Exhibits

10:30 – 11:15 am        FOOD ALLERGY: UPDATES IN PREVENTION, Ruchi Gupta, MD, MPH

11:15 – 12:00 pm         URTICARIA AND ANGIOEDEMA, Tim Craig, MD

12:00 – 12:30 pm        PANEL DISCUSSION, Svetlana Kriegel, MD, Moderator
                                       Summarize evaluation and management modalities in patients with food allergies, urticaria and angioedema

12:30 pm                     LUNCH AND EXHIBITS

1:00 – 2:00 pm            ASTHMA MANAGEMENT IN THE PRIMARY CARE AND BEYOND, Alan Baptist, MD, MPH

2:00 – 2:15 pm            PANEL DISCUSSION, M. Razi Rafeeq, MD, Moderator
                                       Summarize management and treatment modalities for asthma

2:15 pm                       Break and Exhibits

2:30 – 4:00 pm            BREAK OUT SESSIONS
                                        1. DRUG ALLERGY:  PCN & ASA, Debi Lee, MD, Fellow; James Baldwin, MD, Mentor
                                        2. ANAPHYLAXIS, Jenny Sun, MD, Fellow; Anna Kovalszki, MD, Mentor
                                        3. ALLERGEN IMMUNOTHERAPY, Marisa Hodges, MD, Fellow; Alan Baptist, MD, Mentor

4:00 – 4:15 pm            CLOSING REMARKS / EVALUATIONS, M. Razi Rafeeq, MD, Moderator

In compliance with the Americans with Disabilities Act, Toledo Allergy Society requests that any participant in need of accommodation contact Julie_Hemminger@mercy.com

All identified conflicts of interest have been resolved.

Michael Blaiss, MD
Consultant: Pfizer, Merck, Hycor, ALK, Greer, Sanofi, JDP, PMD, DBV

Timothy Craig, DO 
Speaker: CSL Behring, Biocryst, Pharming

Researcher: CSL Behring, Biocryst, Takeda, Ionis

Advisor: Biocryst, Takeda

Alan Baptist, MD, MPH
Researcher: AstraZeneca , Novartis, Takeda

Advisor: AstraZeneca

James Baldwin, MD
Researcher: Healgen Scientific LLC, Access Bio, INC, Discovery Research FFMI, Regeneron

Anna Kovalszki, MD
Speaker: GSK

The following have no relevant financial relationships to disclose:
Jung Yi Sun, MD
Deborah Lee, MD
Marisa Hodges, MD
Ruchi Gupta, MD
M. Razi Rafeeq, MD
Svetlana Kriegel, MD
Julie Hemminger

Available Credit

  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Attendance
Please login or create an account to take this course.